SDS-coated atovaquone nanosuspensions show improved therapeutic efficacy against experimental acquired and reactivated toxoplasmosis by improving passage of gastrointestinal and blood-brain barriers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples